Apr 4, 2018, SynoMC and Shenzhen Institutes of Advanced Technology (SIAT), Chinese Academy of Sciences hosted an initiation ceremony for the newly set up Joint Laboratory for Bacterium-mediated Minicircle-based Anticancer Gene Therapy.

  Dr Zhi-Ying Chen and Dr Vincent Xie from SynoMC, Mr Ya-Lei Bi and Dr Chen-Li Liu from SIAT, and many others, participated in the ceremony.  Having collaborated successfully and sharing similar goals, the two parties will work closely on the construction of vectors, targeted delivery, new product development, technology platform and training of talents, for bacterium-mediated cancer gene therapy.

Aug 2, 2017, SynoMC and Guiyang Yuyang Trading Co. Ltd. jointly set up a subsidary – Guizhou Zhongze Minicircle Biotechnology Co. Ltd. (abbreviated as Zhongze MC) in Guiyang, Guizhou province.  Zhongze MC is responsible to bring to the market an innovative bispecific antibody minicircle DNA product for the treatment of B-cell lymphoma, providing a safe, effective, convenient, affordable and revolutionary therapeutic option.